Primary and secondary prevention of cerebrovascular diseases in young people: an application for individually wearable gadgets as an element of the medical decision-making system

Background. Cerebrovascular disorders are a real tragedy on a global scale. The number of cases of acute cerebral circulatory disorders of this type reaches 400-450 thousand per year. Of particular concern is the increase in the prevalence of ischemic strokes in young ablebodied people. In this regard, primary prevention, comprehensive diagnosis, timely and effective treatment of stroke is the most important medical and social problem. Gadgets like smart watch are becoming increasingly available and can record various types of medical data. This is a unique opportunity to monitor the health of out-patients for a long period of time.

Objective. To test the possibility of implementing primary and secondary prevention programmes using a portable smart gadget in a cohort of patients with cryptogenic stroke and in people who have not suffered a stroke but have risk factors for cerebrovascular disorders.

Results. A programme has been developed to register and store the data on the presence of risk factors for vascular catastrophes in patients and methods of individualized prevention. The key parameters are the data of patients' risk factors recorded in relation to the presence of each clinical symptom with the entry of information into the database according to 'many things to the one' principle. It can be used to accumulate and analyze the data on the presence of risk factors for cerebrovascular disorders, the choice of individualized prevention, and patients' management tactics.

Conclusion. The use of new technologies can lead to the improvement of programmes for the prevention of cerebrovascular disorders. The latest portable smart gadgets are able to continuously monitor various vital parameters, which can radically transform the interaction between a doctor and a patient and contribute to the implementation of individually designed preventive programmes.

1. Dobrynina L. A., Kalashnikova L. A., Pavlova L. N. Ishemicheskiy insul't v molodom vozraste Zhurnal nevrologii i psikhiatrii im. S. S. Korsakova. 2011; 3: 4-8. (In Russ.)

2. Austin H., Chimowitz M. I., Hill H. A., et al. Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke. 2002; 33: 2762-2769.

3. Palleiro O., López B. Etiologic subtypes of ischemic stroke in young adults aged 18 to 45 years: a study of a series of 93 patients. Rev Clin Esp. 2007; 207 (4): 158-165.

4. Putaala J., Metso A. J., Metso T. M., et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009; 40 (4): 1195-1203.

5. Montanaro V. V., Freitas D. D., Ruiz M. C., Cavalcanti E. B., Marinho P. B., Freitas M. C., Oliveira E. M. Ischemic stroke in young adults: Profile of SARAH Hospital Brasília from 2008 to 2012. Neurologist. 2017; 22 (2): 61-63. DOI: 10.1097/NRL.0000000000000110.

6. Eikelboom J. W., Lonn E., Genest J. Jr., et al. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med. 1999; 131: 363-375.

7. Rahemtullah A., van Cott E. M. Hypercoagulation testing in ischemic stroke. Arch Pathol Lab Med. 2007; 131 (6): 890-901.

8. Kalashnikova L. A., Dobrynina L. A., Ustyuzhanina M. K. Gipergomotsisteinemiya i porazhenie golovnogo mozga. Nevrologicheskiy zhurnal. 2004; 9 (3): 48-54. (In Russ.)

9. McCully K. S. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969; 56: 111-128.

10. Vandresse J. H., de Saint Hubert E., Evrard P. Homocystinuria and carotid arteriography. Neuroradiology. 1978; 17: 57-58.

11. Shestakova E., Yavorskaya A. Perspektivy lecheniya i diagnostiki s pomoshch'yu iskusstvennogo intellekta. Tekst: elektronnyy. Fingazeta.ru: [sayt]. URL: https://fingazeta.ru/opinion/eksperty/457390/. (In Russ.)

12. Zaydullin R. Budushchee uzhe nastupilo: kak iskusstvennyy intellekt primenyaetsya v meditsine. Tekst: elektronnyy. vc.ru: [sayt]. URL: https://vc.ru/future/32237-budushchee-uzhe-nastupilo-kak-iskusstvennyy-intellekt-primenyaetsya-v-medicine. (In Russ.)

13. Case M. A., Burwick H. A., Volpp K. G., Patel M. S. Accuracy of smartphone applications and wearable devices for tracking physical activity data. JAMA. 2015; 313 (6): 625-626.

14. Manini T. M., Mendosa T., Battula M., Davudi A., Kheyrkhakhan M., Yang M., Veber E., Fillingim R. B., Rashidi P. Perception of Older Adults Toward Smartwatch Technology for Assessing Pain and Related Patient-Reported Outcomes: Pilot Study. JMIR Mhealth Uhealth. 2019; 7 (3): e10044.

15. Piwek L., Ellis D. A., Andrews S., Joinson A. The Rise of Consumer Health Wearables: Promises and Barriers. PLoS Med. 2016; 13 (2): e1001953.

16. Lu T. K., Fu S. M., Ma M. K.h, Fang K. K., Terner A. M. Healthcare Applications of Smart Watches. A Systematic Review. Clin Inform. 2016; 7 (3): 850-869.

17. Bonura A., Motolese F., Capone F., et al. Smartphone App in Stroke Management: A Narrative Updated Review. J Stroke. 2022; 24 (3): 323-334. DOI: 10.5853/jos.2022.01410. PMID: 36221935; PMCID: PMC9561218.